These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 15776821

  • 1. Compression of controlled-release pellets produced by a hot-melt extrusion and spheronization process.
    Young CR, Dietzsch C, McGinity JW.
    Pharm Dev Technol; 2005; 10(1):133-9. PubMed ID: 15776821
    [Abstract] [Full Text] [Related]

  • 2. Production of spherical pellets by a hot-melt extrusion and spheronization process.
    Young CR, Koleng JJ, McGinity JW.
    Int J Pharm; 2002 Aug 21; 242(1-2):87-92. PubMed ID: 12176229
    [Abstract] [Full Text] [Related]

  • 3. Properties of drug-containing spherical pellets produced by a hot-melt extrusion and spheronization process.
    Young CR, Koleng JJ, McGinity JW.
    J Microencapsul; 2003 Aug 21; 20(5):613-25. PubMed ID: 12909545
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation of Ceolus™ microcrystalline cellulose grades for the direct compression of enteric-coated pellets.
    Kucera SU, DiNunzio JC, Kaneko N, McGinity JW.
    Drug Dev Ind Pharm; 2012 Mar 21; 38(3):341-50. PubMed ID: 21870908
    [Abstract] [Full Text] [Related]

  • 6. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY, Lin KH, Li MJ.
    J Pharm Sci; 2002 Sep 21; 91(9):2040-6. PubMed ID: 12210050
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A, De Beer T, Remon JP, Baeyens W, Foreman P, Vervaet C.
    Eur J Pharm Biopharm; 2008 Sep 21; 70(1):302-12. PubMed ID: 18579353
    [Abstract] [Full Text] [Related]

  • 9. Properties of lipophilic matrix tablets containing phenylpropanolamine hydrochloride prepared by hot-melt extrusion.
    Liu J, Zhang F, McGinity JW.
    Eur J Pharm Biopharm; 2001 Sep 21; 52(2):181-90. PubMed ID: 11522484
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Orodispersible tablets containing taste-masked solid lipid pellets with metformin hydrochloride: Influence of process parameters on tablet properties.
    Petrovick GF, Kleinebudde P, Breitkreutz J.
    Eur J Pharm Biopharm; 2018 Jan 21; 122():137-145. PubMed ID: 29106946
    [Abstract] [Full Text] [Related]

  • 12. Investigations on the Impacts of Drugs or Excipients with Different Physicochemical and Compaction Properties on the Disintegration Behavior of Kollidon®SR-Based Binary Controlled Release Matrix Tablets.
    Obeidat WM, Gharaibeh SFF.
    AAPS PharmSciTech; 2024 Oct 07; 25(7):235. PubMed ID: 39375251
    [Abstract] [Full Text] [Related]

  • 13. Influence of MCC II fraction and storage conditions on pellet properties.
    Krueger C, Thommes M, Kleinebudde P.
    Eur J Pharm Biopharm; 2013 Nov 07; 85(3 Pt B):1039-45. PubMed ID: 23872176
    [Abstract] [Full Text] [Related]

  • 14. Use of the direct compression aid Ludiflash(®) for the preparation of pellets via wet extrusion/spheronization.
    Roblegg E, Schrank S, Griesbacher M, Radl S, Zimmer A, Khinast J.
    Drug Dev Ind Pharm; 2011 Oct 07; 37(10):1231-43. PubMed ID: 21438702
    [Abstract] [Full Text] [Related]

  • 15. Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.
    Abbaspour MR, Sadeghi F, Afrasiabi Garekani H.
    Eur J Pharm Biopharm; 2008 Mar 07; 68(3):747-59. PubMed ID: 17977701
    [Abstract] [Full Text] [Related]

  • 16. Use of extrusion aids for successful production of Kollidon® CL-SF pellets by extrusion-spheronization.
    Loka NC, Saripella KK, Pinto CA, Neau SH.
    Drug Dev Ind Pharm; 2018 Apr 07; 44(4):632-642. PubMed ID: 29183166
    [Abstract] [Full Text] [Related]

  • 17. Physicochemical properties and mechanism of drug release from ethyl cellulose matrix tablets prepared by direct compression and hot-melt extrusion.
    Crowley MM, Schroeder B, Fredersdorf A, Obara S, Talarico M, Kucera S, McGinity JW.
    Int J Pharm; 2004 Jan 28; 269(2):509-22. PubMed ID: 14706261
    [Abstract] [Full Text] [Related]

  • 18. Development of an Abuse- and Alcohol-Resistant Formulation Based on Hot-Melt Extrusion and Film Coating.
    Jedinger N, Schrank S, Fischer JM, Breinhälter K, Khinast J, Roblegg E.
    AAPS PharmSciTech; 2016 Feb 28; 17(1):68-77. PubMed ID: 26206403
    [Abstract] [Full Text] [Related]

  • 19. New co-processed MCC-based excipient for fast release of low solubility drugs from pellets prepared by extrusion-spheronization.
    Goyanes A, Martínez-Pacheco R.
    Drug Dev Ind Pharm; 2015 Mar 28; 41(3):362-8. PubMed ID: 24279425
    [Abstract] [Full Text] [Related]

  • 20. Suitability of κ-carrageenan pellets for the formulation of multiparticulate tablets with modified release.
    Ghanam D, Kleinebudde P.
    Int J Pharm; 2011 May 16; 409(1-2):9-18. PubMed ID: 21335073
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.